The challenges facing large pharmaceutical companies are stark: sales are slowing and research and development costs are rising. There's an overwhelming need to reduce development costs by as much as 30-40 per cent, whilst at the same time significantly shortening development cycle times. Pharmaceutical spend on outsourcing faces double-digit growth for the next three to five years and yet, if outsourcing is to meet these challenges, new models of collaborative and cooperative working are needed now. ''Outsourcing Clinical Development'' offers a guide to these new models and to future clinical outsourcing strategy. There is advice at a strategic level on the basis for an outsourcing strategy and how to work with CROs (clinical research outsourcers); geographical issues, such as low-cost environments. There's also a detailed guide to selecting candidates, and managing the proposal, negotiation and contract process successfully; as well as reviewing the performance of your outsourcing and developing a strategic relationship in the longer term. The pharmaceutical outsourcing function is as complex and as influential a process as the clinical trials themselves. ''Outsourcing Clinical Development'', with a powerful mix of perceptive insight from leading lights in the industry, advice on long-term strategic direction and tools for immediate help is a must-have read for pharmaceutical companies and the CROs that support them.